- Home
- QNTM vs ADGM Comparison
QNTM vs ADGM Comparison
Compare QNTM & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNTM
- ADGM
- Stock Information
- Founded
- QNTM 1998
- ADGM 2011
- Country
- QNTM Canada
- ADGM United States
- Employees
- QNTM N/A
- ADGM N/A
- Industry
- QNTM
- ADGM
- Sector
- QNTM
- ADGM
- Exchange
- QNTM NYSE
- ADGM NYSE
- Market Cap
- QNTM 35.6M
- ADGM 19.7M
- IPO Year
- QNTM N/A
- ADGM N/A
- Fundamental
- Price
- QNTM $17.37
- ADGM $1.54
- Analyst Decision
- QNTM
- ADGM
- Analyst Count
- QNTM 0
- ADGM 0
- Target Price
- QNTM N/A
- ADGM N/A
- AVG Volume (30 Days)
- QNTM 409.1K
- ADGM 60.5K
- Earning Date
- QNTM 08-13-2025
- ADGM 08-25-2025
- Dividend Yield
- QNTM N/A
- ADGM N/A
- EPS Growth
- QNTM N/A
- ADGM N/A
- EPS
- QNTM N/A
- ADGM N/A
- Revenue
- QNTM N/A
- ADGM $576,000.00
- Revenue This Year
- QNTM N/A
- ADGM N/A
- Revenue Next Year
- QNTM N/A
- ADGM N/A
- P/E Ratio
- QNTM N/A
- ADGM N/A
- Revenue Growth
- QNTM N/A
- ADGM 116.54
- 52 Week Low
- QNTM $2.70
- ADGM $0.63
- 52 Week High
- QNTM $38.25
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- QNTM 48.86
- ADGM N/A
- Support Level
- QNTM $18.00
- ADGM N/A
- Resistance Level
- QNTM $24.32
- ADGM N/A
- Average True Range (ATR)
- QNTM 4.27
- ADGM 0.00
- MACD
- QNTM -1.08
- ADGM 0.00
- Stochastic Oscillator
- QNTM 2.47
- ADGM 0.00
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.